Login / Signup

Effect of switching from nucleos(t)ide maintenance therapy to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomized trial.

Hyun Young WooJeong HeoWon Young TakHeon Ju LeeWoo Jin ChungJung Gil ParkSoo Young ParkYoung Joo ParkYu Rim LeeJae Seok HwangYoung Oh Kweon
Published in: PloS one (2022)
(ClinicalTrials.gov; NCT01769833).
Keyphrases
  • hepatitis b virus
  • replacement therapy
  • stem cells
  • liver fibrosis
  • mesenchymal stem cells
  • bone marrow